論文 2020年
論文バックナンバー
2020年
英文
-
Miyazaki T, Yanagihara K, Kakeya H, Izumikawa K, Mukae H, Shindo Y, Yamamoto Y, Tateda K, Tomono K, Ishida T, Hasegawa Y, Niki Y, Watanabe A, Soma K, Kohno S. Daily practice and prognostic factors for pneumonia caused by methicillin-resistant Staphylococcus aureus in Japan: A multicenter prospective observational cohort study. J Infect Cheomother 2020;26(2):242-251. doi: 10.1016/j.jiac.2019.08.018.
-
Tsubouchi T, Suzuki M, Niki M, Oinuma K, Niki M, Kakeya H, Kaneko Y. Complete genome sequence of Acinetobacter baumannii ATCC19606T, which is a model strain of pathogenic bacteria causing nosocomial infection. Microbiology Resource Announcements, 2020;14:9(20):e00289-20.
-
Moriguchi M, Koh H, Hayashi T, Okamura H, Nanno S, Nakashima Y, Nakane T, Imoto W, Yamada K, Kakeya H, Hino M, Nakamae H. Clinical usefulness of very high serum soluble interleukin-2 receptor levels for the detection of tuberculous peritonitis in a patient with chronic myelogenous leukemia. J Infection Chemother, 2020;26(19):1054-1057.
-
Shibata W, Niki M, Sato K, Fujimoto H, Yamada K, Watanabe T, Miyazaki Y, Asai K, Obata Y, Tachibana T, Kawaguchi T, Kaneko Y, Kakeya H. Detection of Rhizopus-specific antigen in human and murine serum and bronchoalveolar lavage. Med Mycol. 2020;1;58(7):958-964. doi: 10.1093/mmy/myaa001.
-
Kuwabara G, Yukawa S, Koichi Yamada K, Imoto W, Yamairi K, Shibata W, Yoshii N, Watanabe T, Asai K, Niki M, Nakaie K, Okada Y, Fujita A, Kaneko Y, Kawaguchi T, Kakeya H. The effect of intervention by an antimicrobial stewardship team on anaerobic bacteremia. Anaerobe, 2020;64:102214. doi: 10.1016/j.anaerobe.2020.102214.
-
Imoto W, Yamada K, Hajika Y, Okamoto K, Myodo Y, Niki M, Kuwabara G, Yamairi K, Shibata W, Yoshii N, Nakaie K, Yoshizawa K, Namikawa H, Watanabe T, Asai K, Moro H, Kaneko Y, Kawaguchi T, Ito Y, KakeyaH. Disseminated Mycobacterium abscessus subsp. massiliense infection in a Good’s syndrome patient negative for human immunodeficiency virus and anti-interferon-γ autoantibody: A case report, BMC Infect Dis 2020;20(1):431. doi: 10.1186/s12879-020-05136-x.
-
Yoshii N, Tochino Y, Fujioka M, Sakazaki H, Maruyama N, Asai K, Kakeya H, Shintaku H, Kawaguchi T. The comparison of the efficacy of baloxavir and neuraminidase inhibitors for patients with influenza A in clinical practice. Intern Med 2020; 59(12):1509-1513. doi: 10.2169/internalmedicine.4117-19.
-
Murakami T, Tokuda T, Nishimura S, Fujii H, Takahashi Y, Yamane K, Inoue K, Yamada K, Kakeya H, Toshihiko Shibata T. Successful treatment of Staphylococcus schleiferi infection after aortic arch repair: In situ aortic arch replacement and domino reconstruction of the debranching graft using autologous iliac artery. Acta Med. Okayama, 2020;74(3):251-255. doi: 10.18926/AMO/59959.
-
Harada N, Shibata W, Koh H, Takashita E, Fujisaki S, Okamura H, Nanno S, Yamada K, Nakamae H, Hino M, Kakeya H. Successful treatment with baloxavir marboxil of a patient with peramivir-resistant influenza A/H3N2 with a dual E119D/R292K substitution after allogeneic hematopoietic cell transplantation: A case report. BMC Infect Dis, 2020;20(1):478. doi: 10.1186/s12879-020-05205-1.
-
Yamada K, Kuwabara G, Imoto W, Yamairi K, Shibata W, Oshima K, Yoshii N, Nakaie K, Niki M, Okada Y, Fujita A, Sakurai N, Kaneko Y, Kakeya H. Blood culture reports by infectious disease physicians can improve the prognosis of bacteremia, including in cases of weekend onset. Intern J Infect Dis, 2020;100:174-179. doi: 10.1016/j.ijid.2020.08.013.
-
Yanagihara K, Matsumoto T, Tokimatsu I, Tsukada H, Fujikura Y, Miki M, Morinaga Y, Sato J, Wakamura T, Kiyota H, Tateda K, Hanaki H, Fujiuchi S, Takahashi M, Kayaba H, Mori Y, Takeda H, Ikeda H, Takahashi H, Konno M, Niitsuma K, Niki Y, Takuma T, Kawana A, Kudo M, Hirano T, Miyazawa N, Aso S, Aoki N, Honma Y, Yamamoto Y, Iinuma Y, Mikamo H, Yamagishi Y, Nakamura A, Kondo S, Kawabata A, Sugaki Y, Yamamoto T, Nishi I, Hamaguchi S, Kakeya H, Fujikawa Y, Mitsuno N, Ukimura A, Yoshida K, Hayashia M, Mikasaa K, Kasahara K, Tokuyasu H, Hino S, Shimizu E, Chikumi H, Fujita M, Kadota J, Hiramatsu K, Suga M, Muranaka H. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese society of chemotherapy, the Japanese association for infectious diseases, and the Japanese society for clinical microbiology in 2016: General view of the pathogens’ antibacterial susceptibility. J Infect Chomother 2020;26(9): 873-881. doi: 10.1016/j.jiac.2020.05.006.
-
Imoto W, Yamada K, Yamairi K, Shibata W, Namikawa H, Yukawa S, Yoshii N, Nakaie K, Hirose A, Koh H, Watanabe T, Asai K, Nakamae H, Kaneko Y, Kawaguchi T, Hino M, Kakeya H. Clinical Characteristics of Rapidly Progressive Fatal Hemorrhagic Pneumonia Caused by Stenotrophomonas maltophilia. Intern Med 2020;59(2):193-198.
-
Imoto W, Kaga S, Noda T, Mizobata Y, Kakeya H. Coronavirus disease with multiple infarctions. QJM 2020;113(12):907-908. doi: 10.1093/qjmed/hcaa240.
-
Izumikawa K, Kakeya H, Sakai F, Shibuya K, Sugita T, Takazono T, Takata T, Tashiro M, Teruya K, Nakamura S, Noguchi H, Hiruma M, Makimura K, Miyazaki T, Miyazaki Y, Yamagishi Y, Yoshida K, Watanabe A. Executive summary of JSMM clinical practice guidelines for diagnosis and treatment of cryptococcosis 2019. Med Mycol J 2020;61(4): 61-89. doi: 10.3314/mmj.20.001.
-
Imoto W, Kaneko Y, Yamada K, Kuwabara G, Yamairi K, Shibata W, Oshima K, Niki M, Nakaie K, Watanabe T, Asai K, Kawaguchi T, Kakeya H. A mouse model of rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia. J Glob Antimicrob Resist, 2020;23:450-455. doi: 10.1016/j.jgar.2020.10.024.
-
Tashiro M, Takazono T, Saijo T, Yamamoto K, Imamura Y, Miyazaki T, Kakeya H, Ando T, Ogawa K, Kishi K, Tokimatsu I, Hayashi Y, Fujiuchi S, Yanagihara K, Miyazaki Y, Ichihara K, Mukae H, Kohno S, Izumikawa K. Selection of Oral Antifungals for Initial Maintenance Therapy in Chronic Pulmonary Aspergillosis: A Longitudinal Analysis. Clin Infect Dis 2020;70(5):835-842. doi: 10.1093/cid/ciz287.
-
Takizawa E, Fujimoto H, Namikawa E, Yamada K, Yamairi K, Shibata W, Kakeya H. A case of Fabry disease in heterozygous female diagnosed by Mulberry body. Risho Byori, 2020;68(6):520-524.
和文
-
掛屋 弘. ESBL, KPC, NDMなどのβラクタマーゼ産生菌. 今日の治療指針2020. 医学書院 2020, pp218-219.
-
中村安孝, 山田康一, 掛屋 弘, 永山勝也. 薬剤の使用動向の指標を用いて薬剤師がすべき薬剤耐性菌対策. 日化療会誌 2020;68:123-131.
-
掛屋 弘. 医学と医療の最前線 肺真菌症の臨床. 日内会誌 2020;109: 293-299.
-
掛屋 弘. 肺真菌症(肺アスペルギルス症、肺クリプトコックス症)の疫学、病態、診断、治療. 呼吸器ジャーナル 呼吸器感染症診療の最前線. 2020; 68(2): 270-278.
-
掛屋 弘. 肺真菌症. 今日の診断指針第8版. 医学書院, 東京, 2020, pp948-950.
-
大島一浩, 桑原 学, 井本和紀、山入和志, 柴多 渉, 山田康一, 切通絢子, 加賀慎一郎, 西村哲郎, 溝端康光, 掛屋 弘. ヒドロキシクロロキン、アジスロマイシン、ファビピラビルによる治療中に心室細動を起こしたCOVID-19肺炎の一例. 日感染誌 2020;94(4):600- 603.
-
柴多 渉, 掛屋 弘. 慢性肺アスペルギルス症の治療方針は? 竹末芳生編. AST虎の巻:日常の疑問に答える! 中外医学社, 東京. 2020, pp109-115.
-
柴多 渉、掛屋 弘. 薬剤耐性カンジダの疫学. 臨床検査 2020;64(7):772-777.
-
山田康一、掛屋 弘. ICTから現場へ! カルバペネム系薬の使用が減らない! Infection Control 夏季増刊, 2020, pp152-158.
-
掛屋 弘. 十三市民病院のコロナ専門病院としての出発に寄せて. 新型コロナウイルス感染症「COVID-19」対応BOOK. 照林社. 2020, pp4-5.
-
掛屋 弘. 慢性肺アスペルギルス症-治療のポイント. 日本医事新報 2020; 5039: 25-32.
-
安部順子、山田康一、吉井直子、柴多 渉、大島一浩、掛屋 弘. 週3回透析患者に対する抗MRSA薬ダプトマイシン投与のシミュレーション-週3回透析後投与において週末に1.5倍量投与は妥当か?-. 臨床薬理2020;51(6):325-330.
-
山田康一,桑原 学,掛屋 弘. 特集:外科,救急,集中治療におけるAntimicrobial Stewardship(抗菌薬適正使用支援)AST 活動による外科感染症診療の変化. 日外感染症会誌 2020;17(4)172 -177.